Q1 2025 Simulations Plus Inc Earnings Call Transcript
Key Points
- Total revenue increased by 31% year-over-year, with a 5% organic growth, indicating strong overall performance.
- Software revenue grew by 41%, with significant contributions from the Clinical Pharmacology and Pharmacometrics (CPP) and Quantitative Systems Pharmacology (QSP) business units.
- The company added 12 new customers and achieved 9 customer upsells, showcasing successful client engagement and expansion.
- The integration of the Adaptive Learning and Insights (ALI) and Medical Communications (MC) business units is progressing well and is in line with expectations.
- The company ended the quarter with a strong backlog of $17.3 million, up 22% sequentially, indicating robust future demand for services.
- The macro environment remains challenging with funding and cost constraints affecting the pharma and biotech sectors.
- Services revenue declined by 9% on an organic basis, impacted by client-driven data delays that postponed project ramp-ups.
- Gross margins decreased compared to the prior year, with Software gross margin dropping from 87% to 75% and Services gross margin from 36% to 26%.
- Net income for the quarter was significantly lower at $0.2 million compared to $1.9 million last year, reflecting a decrease in profitability.
- The company faces ongoing challenges with project delays and budget constraints, which could impact future revenue realization.
Greetings, and welcome to the Simulations Plus first-quarter fiscal 2025 financial results conference call. (Operator Instructions) As a reminder, this conference call is being recorded. It is now my pleasure to introduce your host, Lisa Fortuna, from Financial Profile. Ms. Fortuna, you may now begin.
Welcome to the Simulations Plus first-quarter fiscal 2025 financial results conference call. With me today are Shawn O'Connor, Chief Executive Officer; and Will Frederick, Chief Financial Officer and Chief Operating Officer of Simulations Plus. Please note that our updated -- that we updated our quarterly earnings presentation, which will serve as a supplement to today's prepared remarks. You can access the presentation on our Investor Relations website at www.simulations-plus.com.
After management's commentary, we will open the call for questions. As a reminder, the information discussed today may include forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
